Comparison between the CEDIA and EMIT II immunoassays for the determination of benzodiazepines

Clinica Chimica Acta

Volumn 271, Issue 1, 1998, Pages 1-9

  Way, Barbara A ^a   Walton, Kim G ^b   Koenig, John W ^b   Eveland, Barbara J ^b   Scott, Mitchell G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BJC HEALTHCARE   (United States)

Author keywords

Cloned enzyme donor immunoassay; Drugs of abuse

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BETA GALACTOSIDASE; CHLORDIAZEPOXIDE; CLORAZEPATE; DIAZEPAM; DRUG METABOLITE; HALAZEPAM; LORAZEPAM; MEDAZEPAM; MIDAZOLAM; NORDAZEPAM; OXAZEPAM; OXAZOLAM; PRAZEPAM; SERTRALINE; TEMAZEPAM; TRIAZOLAM;

ANALYZER; ARTICLE; DRUG ABUSE; DRUG SCREENING; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MASS SPECTROMETRY; PRIORITY JOURNAL; URINE;

BENZODIAZEPINES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IMMUNOASSAY; LORAZEPAM; MEDICAL RECORDS; SENSITIVITY AND SPECIFICITY; SUBSTANCE-RELATED DISORDERS;

EID: 0032498944     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(97)00227-1     Document Type: Article

References (15)

1. Armbruster D.A., Hubster E.C., Kaufman M.S., Ramon M.K. Cloned enzyme donor immunoassay (CEDIA) for drugs-of-abuse screening. Clin Chem. 41:1995;92-98.
2. Meatherall R. GC-MS confirmation of urinary benzodiazepine metabolites. J Anal Toxicol. 18:1994;369-381.
3. Wu A.H.B., Forte E., Casella G., Sun K., Hemphill G., Foery R., Schanzenbach H. CEDIA for screening drugs-of-abuse in urine and the effect of adulterants. J Forensic Sci. 40:1995;614-618.
4. Kopetzki E., Lehnert K., Buckel P. Enzymes in diagnostics: achievements and possibilities of recombinant DNA technology. Clin Chem. 40:1994;688-704.
5. Beck O., Lafolie P., Hjemdahl P., Borg S., Odelius G., Wirbing P. Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: two techniques evaluated and modified for improved performance. Clin Chem. 38:1992;271-275.
6. Fraser A.D., Bryan W., Isner A.F. Urinary screening for alprazolam and its major metabolites by the Abbott ADX and TDX analyzers with confirmation by GC/MS. J Anal Toxicol. 15:1991;25-29.
7. Beck O., Lafolie P., Odelius G., Boreus L.O. Immunological screening of benzodiazepines in urine; improved detection of oxazepam intake. Toxicol Lett. 52:1990;7-14.
8. Poklis A., Edinboro L.E. Discordant benzodiazepine results by immunoassay. J Anal Toxicol. 18:1994;425-426.
9. Borggaard B., Joergensen I. Urinary screening for benzodiazepines with radioreceptor assay:comparison with EMITO d.a.u. benzodiazepine assay and high-performance liquid chromatography. J Anal Toxicol. 18:1994;243-246.
10. Oellerich M. Enzyme immunoassays in clinical chemistry: present status and trends. J Clin Chem Clin Biochem. 18:1980;197-208.
11. Henderson D.R., Friedman S.B., Harris J.D., Manning W.B., Zoccoli M.A. CEDIA, a new homogeneous immunoassay system. Clin Chem. 32:1986;1637-1641.
12. Wong E.C.C., Koenig J., Turk J. Potential interference of cyclobenzaprine and norcyclobenzaprine with HPLC measurement of amitryptyline and nortryptyline: resolution by GC-MS analysis. J Anal Toxicol. 19:1995;218-224.
13. Langner J.D., Gan B.K., Liu R.H., Baugh L.D., Chand P., Weng J.L., Edwards C., Walia A.S. Enzymatic digestion, solid-phase extraction, and gas chromatography/mass spectrometry of derivatized intact oxazepam in urine. Clin Chem. 37:1991;1595-1601.
14. Baselt RC. Disposition of toxic drugs and chemicals in man. 2nd ed. Davis, CA: Biomedical Publications, 1982;229,437,455,654-655.
15. Nishikawa T., Ohtani H., Herold D.A., Fitzgerald R.L. Comparison of assay methods for benzodiazepines in urine: a receptor assay, two immunoassays, and gas chromatography-mass spectrometry. Am J Clin Pathol. 107:1997;345-352.